The article reports on the cost effectiveness of using insulin glargine for the treatment of insulin-naive and non-insulin-naive patients with type 2 diabetes mellitus (T2DM) compared to insulin suspension isophane (NPH) based on a study presented at the 10th Annual European Congress of the ...
Comparison of insulin glargine versus NPH insulin treatment among patients with type 2 diabetes based on review of clinical trial resultsMaternal MortalityHealth systemsSystematic ReviewResearch EvidenceBACKGROUND D. Allergic rhinitis and asthma (ARA) are frequent respiratory diseases that often coexist, ...
Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany. J Med Econ. 2012;15(Suppl 2):14–27.Pfohl M, Schadlich PK, Dippel FW, et al. Health eco- nomic evaluation of insulin glargine vs NPH insulin in in- tens...
The aim of this study was to compare the subcutaneous absorption characteristics of insulin glargine with NPH insulin in patients with Type 2 diabetes. In this single-dose, double-blind, randomized, two-way crossover study, 14 patients with Type 2 diabetes (aged 40 - 70 years) previously untr...
Use of insulin glargine vs NPH vs diet in pregnant women with gestational diabetesUse of insulin glargine vs NPH vs diet in pregnant women with gestational diabetesC.A., NegratoM.F., TeixeiraC.A., SilvaA., RafachoA.C., DemarchiS
Insulin glargine, a new long-acting insulin analogue, provides constant, peakless insulin release following once-daily administration and is associated with fewer hypoglycaemic episodes, despite metabolic control equivalent to that achieved with NPH human basal insulin.关键词: Type 1 diabetes treatment ...
Objective To study the effectiveness and safety of insulin glargine versus isophane insulin as add-on therapy to previous OHA in senile obese type 2 diabetic patients who failed to control their blood glucose with oral hypoglycemic agents(OHA).Methods Sixty-one patients who failed to control their...
As glargine, an analog of human insulin, is increasingly used during pregnancy, a meta-analysis assessed its safety in this population. A systematic literature search identified studies of gestational or pregestational diabetes comparing use of insulin glargine with human NPH insulin, with at least ...
(INN);— detemirinsulina detemir;— glargineinsulina glargina;— gluli-sineinsulina glulisina;— lisproinsulina lispro;intermediate-acting —insulina de acción intermedia;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de ...
正常ビーグル犬3頭を用いて,Insulin GlargineおよびNPH insulinを皮下投与後の血糖降下作用 についてグルコース注入率(GIR)を用L、て比較検討した。NPH insulinの最大ピークは投与後5時間で現 れ,一方insulin glargineは7時間で現れた。さらに,投与後12時間までのGIRAUCをNPH insulinと insulin glargine...